Cargando…
Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer
BACKGROUND: We investigated the utility of a molecular classifier tool and genetic alterations for predicting prognosis in Japanese patients with endometrial cancer. METHODS: A total of 1029 patients with endometrial cancer from two independent cohorts were classified into four molecular subtype gro...
Autores principales: | Asami, Yuka, Kobayashi Kato, Mayumi, Hiranuma, Kengo, Matsuda, Maiko, Shimada, Yoko, Ishikawa, Mitsuya, Koyama, Takafumi, Komatsu, Masaaki, Hamamoto, Ryuji, Nagashima, Minoru, Terao, Yasuhisa, Itakura, Atsuo, Kohno, Takashi, Sekizawa, Akihiko, Matsumoto, Koji, Kato, Tomoyasu, Shiraishi, Kouya, Yoshida, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070437/ https://www.ncbi.nlm.nih.gov/pubmed/36797358 http://dx.doi.org/10.1038/s41416-023-02203-3 |
Ejemplares similares
-
Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
por: Hiranuma, Kengo, et al.
Publicado: (2023) -
Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
por: Kobayashi Kato, Mayumi, et al.
Publicado: (2022) -
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2022) -
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
por: Takayanagi, Daisuke, et al.
Publicado: (2021) -
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Kuno, Ikumi, et al.
Publicado: (2021)